Core Insights - HeartSciences Inc. has announced that its MyoVista Insights™ platform has received Epic Toolbox designation for the ECG Management System category, marking a significant milestone in its interoperability strategy [1][3]. Group 1: Product Overview - MyoVista Insights is a cloud-native ECG management and analysis platform designed to enhance workflow efficiency and support clinical decision-making [2]. - The platform integrates with hospital information systems and electronic health records (EHRs), including Epic, through HL7v2 order and results workflows, single sign-on (SSO), and SMART on FHIR [2]. - MyoVista Insights is device-agnostic and aims to improve clinical efficiency and decision-making through the integration of artificial intelligence (AI) [5]. Group 2: Strategic Importance - The Epic Toolbox designation is part of HeartSciences' strategy to enable seamless integration of MyoVista Insights into clinical workflows and expand access across healthcare systems [3]. - The company emphasizes the importance of interoperability in enhancing the usability of its platform within existing clinical workflows [3].

Core Viewpoint - HeartSciences Inc. is set to present at the Investor Summit Group Virtual Conference on March 25, 2026, focusing on its advancements in electrocardiography through AI integration [1][3]. Group 1: Company Overview - HeartSciences is a healthcare information technology company that enhances ECG/EKG usage via AI integration [4]. - The MyoVista Insights platform is a next-generation ECG management system aimed at improving clinical efficiency and decision-making [4]. - The MyoVista wavECG device offers conventional ECG functionality while incorporating AI-enabled solutions [4]. Group 2: Conference Details - The conference will feature a corporate presentation by CEO Andrew Simpson, discussing the company's business strategy, recent milestones, and growth catalysts [3]. - HeartSciences will engage in virtual one-on-one meetings with qualified investors on March 26, 2026 [3][6]. - Registration for one-on-one meetings can be done through the HeartSciences Investor Summit [3]. Group 3: Investor Engagement - CEO Andrew Simpson emphasized the company's commitment to expanding its investor base and increasing visibility in capital markets through participation in the conference [4].

Core Insights - HeartSciences Inc. has announced the commercial release of MyoVista Insights™ version 1.1, enhancing usability and clinical interpretation capabilities of ECG systems [1][2] - The platform is designed to improve workflow efficiency and expand interoperability across various ECG devices, making it a vendor and device agnostic solution [2][3] Product Features - MyoVista Insights is a cloud-native ECG management system that integrates AI ECG algorithm models from multiple partners, streamlining data management and improving workflow efficiency [2] - The updated version 1.1 provides a more intuitive platform for cardiac care, allowing clinicians to quickly interpret complex ECG data and make informed decisions [3] Market Position - Since its launch in May 2025, MyoVista Insights has received strong validation from early adopters and is currently in commercial discussions with several leading healthcare institutions [2] - The company aims to announce key customer deployments in the near term, indicating a positive market reception and potential growth opportunities [2]